GMVD - NASDAQ IPO, page-1704

Well on what little I know (really based on when ASX listed and G13 and others on HC) it has some revenue that has grown (how much?). It's product is good and not expensive for those who need life monitoring. It exists in both consumer and commercial markets where competition is coming quick (though the product range may not be up to GMVD spec).

I feel the new GMVD needs to acknowledge that it cannot be a one man band. The Australian sh may be on bread and water for refusing the Dr his shares but the Americans have spanked him in getting the current proposed listing. How else to explain the complete dud of the first listing last October. Given Dr Yacov was driving the listing, I am hoping the Dr's one-eye view of himself has been knocked down a peg (or two) and I would sincerely hope he allows a more consensus operation. I would even go so far and say that he should not have an executive role.

Looking forward: Like G13, getting the fact from fiction may be decisive. But the company needs to be very weary of doing the ASX stuff on the Nasdaq and as I said a more consensus way forward helps.